The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study.
Postepy dermatologii i alergologii（2023）
摘要
Add-on omalizumab was effective and well-tolerated in Slovakian patients, complementing the results observed in the overall population of eXpeRience.
更多查看译文
关键词
asthma exacerbations,global evaluation of treatment effectiveness,lung function,omalizumab,real-world evidence,severe allergic asthma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要